PPAR-α activation by agonists may have an anticancer effect on colorectal adenocarcinoma, and nuclear expression of PPAR-α may be a therapeutic target for colorectal adenocarcinoma. The gene discussed is PPARA; the disease is colorectal adenocarcinoma.